Total planned funding: $433,832,136
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $121,775,917 |
Mozambique | $70,911,156 |
Zambia | $49,400,536 |
South Africa | $25,056,442 |
Vietnam | $18,628,165 |
Kenya | $17,823,121 |
India | $12,464,357 |
Haiti | $10,464,552 |
Côte d'Ivoire | $10,047,307 |
Burundi | $9,798,411 |
Democratic Republic of the Congo | $9,382,420 |
Tanzania | $9,063,312 |
Botswana | $8,569,723 |
Indonesia | $7,306,794 |
Ghana | $6,982,500 |
Papua New Guinea | $5,981,191 |
Uganda | $4,919,324 |
Angola | $4,716,719 |
Zimbabwe | $4,344,201 |
Rwanda | $4,308,060 |
South Sudan | $3,435,929 |
Asia Regional Program | $3,400,093 |
Malawi | $3,313,446 |
Eswatini | $3,167,187 |
Caribbean Region | $2,525,420 |
Cambodia | $2,025,000 |
Namibia | $1,947,275 |
Ethiopia | $1,373,578 |
Dominican Republic | $450,000 |
Lesotho | $250,000 |
Central Asia Region | $0 |
Organizational Types
NGO | $433,832,136 |
Program Areas
Care | $136,831,049 |
Treatment | $114,312,700 |
Prevention | $97,918,427 |
Governance and Systems | $47,004,106 |
Testing | $37,765,854 |
Budget Codes
HTXS: Treatment: Adult Treatment | $102,009,598 |
HKID: Care: Orphans and Vulnerable Children | $61,169,560 |
HVOP: Sexual Prevention: Other Sexual Prevention | $54,930,824 |
HBHC: Care: Adult Care and Support | $52,870,032 |
HVCT: Testing: HIV Testing and Counseling | $37,765,854 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $29,523,375 |
HLAB: Laboratory Infrastructure | $17,891,452 |
OHSS: Health Systems Strengthening | $15,115,923 |
HVSI: Strategic Information | $13,996,731 |
PDTX: Treatment: Pediatric Treatment | $12,303,102 |
HVTB: Care: TB/HIV | $11,867,817 |
PDCS: Care: Pediatric Care and Support | $10,923,640 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,288,233 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,246,141 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,958,549 |
HMIN: Biomedical Prevention: Injection Safety | $521,544 |
HMBL: Biomedical Prevention: Blood Safety | $449,761 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$433,832,136
View countries